The Biological Foundations of Sarcopenia

Established and Promising Markers

S.A.M.B.A. project, Martina Casati, Andrea Saul Costa, Daniele Capitanio, Luisa Ponzoni, Evelyn Ferri, Simone Agostini, Elisa Lori

Research output: Contribution to journalReview article

Abstract

Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health issues in older adults, given its high prevalence accompanied by huge clinical and socioeconomic implications. Age-related changes in skeletal muscle can be attributed to mechanisms both directly and indirectly related to muscle homeostasis. Indeed, a wide spectrum of age-related modifications in the organism was shown to play a key role in the pathogenesis of sarcopenia. Not surprisingly, sarcopenia has sometimes been indicated as a syndrome stemming from the aging process, and not as univocal standalone disease. Due to the multidimensionality of sarcopenia, a single biomarker approach is not enough to explain the biology of this condition. The aim of this review is to suggest innovative and promising sarcopenia markers investigating the link between skeletal muscle and brain. Indeed, as a neurological origin of sarcopenia has been hypothesized, a new perspective on sarcopenia biomarkers may focus on the dysfunction of the neuromuscular junctions (NMJs). The core SNARE synaptosomal-associated protein of 25 kDa (SNAP25) accumulates in the plasma membrane of nerve terminals at NMJs and regulates exocytosis at peripheral and central synapses. Interestingly, mice studies have shown that SNAP25 affects the neuromuscular function. SNARE complex and, in particular, SNAP25 may represent a promising pathway to explore the molecular and cellular mechanisms regulating muscular homeostasis and concur at profiling the sarcopenia biological background.

Original languageEnglish
Article number184
JournalFrontiers in Medicine
Volume6
DOIs
Publication statusPublished - Aug 13 2019

Fingerprint

Sarcopenia
Synaptosomal-Associated Protein 25
SNARE Proteins
Neuromuscular Junction
Skeletal Muscle
Homeostasis
Biomarkers
Exocytosis
Muscle Strength
Synapses
Cell Membrane
Muscles
Health

Keywords

  • aging
  • biomarkers
  • neuromuscular junction
  • sarcopenia
  • SNAP25

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The Biological Foundations of Sarcopenia : Established and Promising Markers. / S.A.M.B.A. project ; Casati, Martina; Costa, Andrea Saul; Capitanio, Daniele; Ponzoni, Luisa; Ferri, Evelyn; Agostini, Simone; Lori, Elisa.

In: Frontiers in Medicine, Vol. 6, 184, 13.08.2019.

Research output: Contribution to journalReview article

@article{eeb5e6c08e52456492a09a609b8ebc34,
title = "The Biological Foundations of Sarcopenia: Established and Promising Markers",
abstract = "Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health issues in older adults, given its high prevalence accompanied by huge clinical and socioeconomic implications. Age-related changes in skeletal muscle can be attributed to mechanisms both directly and indirectly related to muscle homeostasis. Indeed, a wide spectrum of age-related modifications in the organism was shown to play a key role in the pathogenesis of sarcopenia. Not surprisingly, sarcopenia has sometimes been indicated as a syndrome stemming from the aging process, and not as univocal standalone disease. Due to the multidimensionality of sarcopenia, a single biomarker approach is not enough to explain the biology of this condition. The aim of this review is to suggest innovative and promising sarcopenia markers investigating the link between skeletal muscle and brain. Indeed, as a neurological origin of sarcopenia has been hypothesized, a new perspective on sarcopenia biomarkers may focus on the dysfunction of the neuromuscular junctions (NMJs). The core SNARE synaptosomal-associated protein of 25 kDa (SNAP25) accumulates in the plasma membrane of nerve terminals at NMJs and regulates exocytosis at peripheral and central synapses. Interestingly, mice studies have shown that SNAP25 affects the neuromuscular function. SNARE complex and, in particular, SNAP25 may represent a promising pathway to explore the molecular and cellular mechanisms regulating muscular homeostasis and concur at profiling the sarcopenia biological background.",
keywords = "aging, biomarkers, neuromuscular junction, sarcopenia, SNAP25",
author = "{S.A.M.B.A. project} and Martina Casati and Costa, {Andrea Saul} and Daniele Capitanio and Luisa Ponzoni and Evelyn Ferri and Simone Agostini and Elisa Lori",
year = "2019",
month = "8",
day = "13",
doi = "10.3389/fmed.2019.00184",
language = "English",
volume = "6",
journal = "Frontiers in Medicine",
issn = "2296-858X",
publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - The Biological Foundations of Sarcopenia

T2 - Established and Promising Markers

AU - S.A.M.B.A. project

AU - Casati, Martina

AU - Costa, Andrea Saul

AU - Capitanio, Daniele

AU - Ponzoni, Luisa

AU - Ferri, Evelyn

AU - Agostini, Simone

AU - Lori, Elisa

PY - 2019/8/13

Y1 - 2019/8/13

N2 - Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health issues in older adults, given its high prevalence accompanied by huge clinical and socioeconomic implications. Age-related changes in skeletal muscle can be attributed to mechanisms both directly and indirectly related to muscle homeostasis. Indeed, a wide spectrum of age-related modifications in the organism was shown to play a key role in the pathogenesis of sarcopenia. Not surprisingly, sarcopenia has sometimes been indicated as a syndrome stemming from the aging process, and not as univocal standalone disease. Due to the multidimensionality of sarcopenia, a single biomarker approach is not enough to explain the biology of this condition. The aim of this review is to suggest innovative and promising sarcopenia markers investigating the link between skeletal muscle and brain. Indeed, as a neurological origin of sarcopenia has been hypothesized, a new perspective on sarcopenia biomarkers may focus on the dysfunction of the neuromuscular junctions (NMJs). The core SNARE synaptosomal-associated protein of 25 kDa (SNAP25) accumulates in the plasma membrane of nerve terminals at NMJs and regulates exocytosis at peripheral and central synapses. Interestingly, mice studies have shown that SNAP25 affects the neuromuscular function. SNARE complex and, in particular, SNAP25 may represent a promising pathway to explore the molecular and cellular mechanisms regulating muscular homeostasis and concur at profiling the sarcopenia biological background.

AB - Sarcopenia, the progressive loss of muscle mass and strength, is one of the major health issues in older adults, given its high prevalence accompanied by huge clinical and socioeconomic implications. Age-related changes in skeletal muscle can be attributed to mechanisms both directly and indirectly related to muscle homeostasis. Indeed, a wide spectrum of age-related modifications in the organism was shown to play a key role in the pathogenesis of sarcopenia. Not surprisingly, sarcopenia has sometimes been indicated as a syndrome stemming from the aging process, and not as univocal standalone disease. Due to the multidimensionality of sarcopenia, a single biomarker approach is not enough to explain the biology of this condition. The aim of this review is to suggest innovative and promising sarcopenia markers investigating the link between skeletal muscle and brain. Indeed, as a neurological origin of sarcopenia has been hypothesized, a new perspective on sarcopenia biomarkers may focus on the dysfunction of the neuromuscular junctions (NMJs). The core SNARE synaptosomal-associated protein of 25 kDa (SNAP25) accumulates in the plasma membrane of nerve terminals at NMJs and regulates exocytosis at peripheral and central synapses. Interestingly, mice studies have shown that SNAP25 affects the neuromuscular function. SNARE complex and, in particular, SNAP25 may represent a promising pathway to explore the molecular and cellular mechanisms regulating muscular homeostasis and concur at profiling the sarcopenia biological background.

KW - aging

KW - biomarkers

KW - neuromuscular junction

KW - sarcopenia

KW - SNAP25

UR - http://www.scopus.com/inward/record.url?scp=85072728725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072728725&partnerID=8YFLogxK

U2 - 10.3389/fmed.2019.00184

DO - 10.3389/fmed.2019.00184

M3 - Review article

VL - 6

JO - Frontiers in Medicine

JF - Frontiers in Medicine

SN - 2296-858X

M1 - 184

ER -